Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 158Terminated 56Recruiting 22Unknown 21Active not recruiting 17Withdrawn 11Not yet recruiting 5Suspended 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms 5Stomach Neoplasms 2Recurrence 2Head and Neck Neoplasms 2HER2-positive Breast Cancer 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Squamous Cell Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Gastroesophageal Junction Cancer 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Advanced or Metastatic Squamous Non-Small Cell Lung Cancer 1Advanced Solid Tumors 1Advanced Pancreatic Cancer 1Advanced Non-small Cell Lung Cancer 1Advanced Non-Small Cell Lung Cancer 1Advanced Malignant Neoplasm 1Advanced Esophageal Carcinoma 1Advanced Breast Cancer 1

Interventions

Androgen Antagonists 10darolutamide 6Magnetic Resonance Spectroscopy 6apalutamide 5Docetaxel 5enzalutamide 4Specimen Handling 4Radiotherapy 4Radiosurgery 4Abiraterone Acetate 4Electroacupuncture 3Brachytherapy 3pembrolizumab 2bicalutamide 2Standard of Care 2Resistance Training 2Radiation 2Prednisone 2Pluvicto 2Interviews as Topic 2Gonadotropin-Releasing Hormone 2Glutamate Carboxypeptidase II 2Bone Density 2Absorptiometry, Photon 2testosterone 17 beta-cypionate 1relugolix 1perflutren 1olaparib 1luprolide acetate gel depot 1fluciclovine F-18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatic Neoplasms × Docetaxel × Clear all
NCT07316686 2026-05-18

Lutécio

Instituto do Cancer do Estado de São Paulo

Phase 1 Not yet recruiting
18 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07590934 2026-05-15

PROSPECTOR

AstraZeneca

Phase 1/2 Not yet recruiting
152 enrolled
Genitourinary

Prostatic Neoplasms

NCT07333066 2026-01-12

REINFORCE

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Phase 3 Not yet recruiting
320 enrolled
Genitourinary

Prostatic Neoplasms

NCT07268794 2025-12-08

CONVERT-HB1

Fudan University

Phase 2 Not yet recruiting
112 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Medical University of Vienna

Not yet recruiting
500 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡